Evidence map›Paper›PMID 34996508›Full record

ArticleParasites & vectors2022

Characterization of Anopheles gambiae D7 salivary proteins as markers of human-mosquito bite contact.

Brenda Oseno, Faith Marura, Rodney Ogwang, Martha Muturi, James Njunge, Irene Nkumama, Robert Mwakesi, Kennedy Mwai, Martin K Rono, Ramadhan Mwakubambanya and 2 more

Open access · goldAbstract read
In one paragraph

Article in Parasites & vectors, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Antibodies toFrontiers in immunology · 2024
    Article
  7. Humoral Immune Responses toInfection and drug resistance · 2023
    Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 4 countries.

Brenda OsenoKEMRI-Wellcome Trust Research Programme CGMRC, P.O. Box 230-80108, Kilifi, Kenya.
Faith MaruraKEMRI-Wellcome Trust Research Programme CGMRC, P.O. Box 230-80108, Kilifi, Kenya.
Rodney OgwangKEMRI-Wellcome Trust Research Programme CGMRC, P.O. Box 230-80108, Kilifi, Kenya.
Martha MuturiKEMRI-Wellcome Trust Research Programme CGMRC, P.O. Box 230-80108, Kilifi, Kenya.
James NjungeKEMRI-Wellcome Trust Research Programme CGMRC, P.O. Box 230-80108, Kilifi, Kenya.
Irene NkumamaKEMRI-Wellcome Trust Research Programme CGMRC, P.O. Box 230-80108, Kilifi, Kenya.
Robert MwakesiKEMRI-Wellcome Trust Research Programme CGMRC, P.O. Box 230-80108, Kilifi, Kenya.
Kennedy MwaiKEMRI-Wellcome Trust Research Programme CGMRC, P.O. Box 230-80108, Kilifi, Kenya.
Martin K RonoKEMRI-Wellcome Trust Research Programme CGMRC, P.O. Box 230-80108, Kilifi, Kenya.
Ramadhan MwakubambanyaEgerton University, P.O. Box 536-20115, Nakuru, Kenya.
Faith OsierKEMRI-Wellcome Trust Research Programme CGMRC, P.O. Box 230-80108, Kilifi, Kenya.
James TujuKEMRI-Wellcome Trust Research Programme CGMRC, P.O. Box 230-80108, Kilifi, Kenya. Jtuju@kemri-wellcome.org.ORCID http://orcid.org/0000-0002-0624-1791
Kenya Medical Research Institute · KEEgerton University · KEHeidelberg University · DEPwani University · KEUniversity of the Witwatersrand · ZA

Funding

European and Developing Countries Clinical Trials Partnership TMA2015SF-1001Wellcome TrustWellcome Trust 107769/Z/10/Z
6 · The paper itself

Abstract

backgroundMalaria is transmitted when infected Anopheles mosquitoes take a blood meal. During this process, the mosquitoes inject a cocktail of bioactive proteins that elicit antibody responses in humans and could be used as biomarkers of exposure to mosquito bites. This study evaluated the utility of IgG responses to members of the Anopheles gambiae D7 protein family as serological markers of human-vector contact.

methodsThe D7L2, D7r1, D7r2, D7r3, D7r4 and SG6 salivary proteins from An. gambiae were expressed as recombinant antigens in Escherichia coli. Antibody responses to the salivary proteins were compared in Europeans with no prior exposure to malaria and lifelong residents of Junju in Kenya and Kitgum in Uganda where the intensity of malaria transmission is moderate and high, respectively. In addition, to evaluate the feasibility of using anti-D7 IgG responses as a tool to evaluate the impact of vector control interventions, we compared responses between individuals using insecticide-treated bednets to those who did not in Junju, Kenya where bednet data were available.

resultsWe show that both the long and short forms of the D7 salivary gland antigens elicit a strong antibody response in humans. IgG responses against the D7 antigens reflected the transmission intensities of the three study areas, with the highest to lowest responses observed in Kitgum (northern Uganda), Junju (Kenya) and malaria-naïve Europeans, respectively. Specifically, the long form D7L2 induced an IgG antibody response that increased with age and that was lower in individuals who slept under a bednet, indicating its potential as a serological tool for estimating human-vector contact and monitoring the effectiveness of vector control interventions.

conclusionsThis study reveals that D7L2 salivary antigen has great potential as a biomarker of exposure to mosquito bites and as a tool for assessing the efficacy of vector control strategies such as bednet use.

Indexed as

AdolescentAnimalsAnophelesBiomarkersChildChild, PreschoolCohort StudiesCross-Sectional StudiesEnzyme-Linked Immunosorbent AssayFemaleHumansImmunoglobulin GInfantInsect Bites and StingsKenyaNerve Tissue ProteinsBiomarkersD-7 antigenImmunoglobulin GNerve Tissue ProteinsSalivary Proteins and PeptidesAnopheles gambiaeBiomarker of exposureInfectious bitesMalariaPlasmodium falciparum

Identifiers

PMID34996508
PMCPMC8742437
OpenAlexW4205894633

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.